DIA Awarded $1.25M Direct to Phase II SBIR with AFWERX
By
DIA

FOR IMMEDIATE RELEASE - August 29, 2024

DIA Awarded $1.25M Direct to Phase II SBIR with AFWERX

DIA will collaborate Air Combat Command (ACC) to expand the environmental operating conditions for our real-time salivary cortisol sensor

Newark, NJ – DIA (legal name: E-Sentience, Inc.) announces it has been selected by AFWERX for a SBIR Direct-to-Phase II contract in the amount of $1,249,993.00 focused on our real-time salivary cortisol sensor to address the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on August 9, 2024, DIA will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America.

Quote From Company

The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government.

“DIA is honored to begin working with ACC to use real-time cortisol sensing to help pilots monitor, manage and optimize their cognitive and physical performance. We are excited to continue to show that our technology is truly groundbreaking in its capability to make biomarker sensing de cada dia – every day.”

About DIA

DIA is building a platform technology that uses non-invasive devices to measure key biomarkers of health and human performance in real time. Our first product is a portable device that measures cortisol in a 0.1 mL sample of saliva. Cortisol is a steroid hormone made by the kidneys that is commonly referred to as “the stress hormone,” as cortisol levels rise in states of both acute and chronic physical & emotional stress. DIA envisions a world where individuals can measure a panel of biomarkers de cada dia – every day – in minutes and at an affordable cost, to improve mental, physical and emotional wellness.

About AFRL

The Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit www.afresearchlab.com.

About AFWERX

As the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 370 military, civilian and contractor personnel at five hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has executed over 6,100 new contracts worth more than $4 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: www.afwerx.com.  

Company Press Contact:
Sloane Tilley

CEO & Founder

[email protected]

Published on
August 29, 2024